Connecting knowledge, people and ideas to advance health innovation

Events
News

09.02.2026 12.02.2026 San Diego, USA

Advanced Therapies Week

18.02.2026 Barcelona

ATMP Series: Biomanufacturing

19.02.2026 Barcelona

Presentació Informe BioRegió 2025

23.03.2026 Sala d'actes de l'Edifici Central del VHIR (Planta 0)

ATMP Catalonia Series: From Preclinical Discovery to First-in-Human Trials

21.04.2026 22.04.2026 Barcelona

Medical Forum - II Edición Advanced Therapies Forum

28.04.2026 30.04.2026 Roma, IT

Cell and Gene - Meeting on the Med

06.05.2026 09.05.2026 Dublin, IR

International Society for Cell & Gene Therapy Annual Meeting

07.09.2026 09.09.2026 Barcelona

Advanced Therapies Europe

10.02.26

Gyala Therapeutics initiates Phase I/IIa clinical trial of a CAR-T cell therapy for acute leukemias with limited treatment options

26.01.26

ATMP Catalonia launches new identity and website to strengthen its international positioning

06.11.25

SpliceBio has closed a €119M financing round, the largest for a biotech company in Spain

29.10.25

Hospital del Mar Research Institute and the Blood and Tissue Bank are launching a new program on Cellular Therapy and Substances of Human Origin (SoHo)

18.09.25

Catalonia takes centre stage at the PRECISEU Best Practice Recognition 2025

18.09.25

Hipra will invest €500M in a new biotechnology hub that will create more than 1,000 jobs

09.08.25

Integra Therapeutics raises €10.7M to advance its FiCAT gene writing platform

27.05.25

Theriva Biologics has announced the primary efficacy and safety results from its phase 2b VIRAGE study

29.04.25

The new CAR-T therapy at Hospital de Sant Pau for the treatment of lymphoma has achieved positive results in a high proportion of refractory patients

17.03.25

EsoBiotec, a startup backed by Invivo Ventures, has announced a $1B acquisition agreement with AstraZeneca, strengthening the international presence and recognition of Catalonia’s entrepreneurial ecosystem

13.03.25

SpliceBio has dosed the first patient in its Astra clinical trial with a gene therapy for inherited retinal diseases

13.02.25

OneChain ImmunoTherapeutics has been selected by the support unit of the Innovation Adoption in the Health System Program (PASS)

17.02.25

Biocat presents the 2024 BioRegion Report

04.02.25